| 1 |
3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs
Nunes AS, Barros AS, Costa EC, Moreira AF, Correia IJ
Biotechnology and Bioengineering, 116(1), 206, 2019 |
| 2 |
Antibody drug conjugates
Bakhtiar R
Biotechnology Letters, 38(10), 1655, 2016 |
| 3 |
Clinical Significance of Serum Biomarkers in Pediatric Solid Mediastinal and Abdominal Tumors
Sandoval JA, Malkas LH, Hickey RJ
International Journal of Molecular Sciences, 13(1), 1126, 2012 |
| 4 |
Conversion of the anti-tumor agent tasidotin (ILX651) to its active metabolite by prolyl oligopeptidase
Deutch CE, Krumbholz R, Schmid SM, Bonate PL, Jurutka PW
Enzyme and Microbial Technology, 46(3-4), 246, 2010 |
| 5 |
Preparation and characterization of self-assembled polymer-metal complex micelle from cis-dichlorodiammineplatinum(II) and poly(ethylene glycol)-poly(alpha,beta-aspartic acid) block copolymer in an aqueous medium
Nishiyama N, Yokoyama M, Aoyagi T, Okano T, Sakurai Y, Kataoka K
Langmuir, 15(2), 377, 1999 |
| 6 |
Three-dimensional simulation of IgG delivery to tumors
Wang CH, Li J
Chemical Engineering Science, 53(20), 3579, 1998 |
| 7 |
Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
Arap W, Pasqualini R, Ruoslahti E
Science, 279(5349), 377, 1998 |
| 8 |
Tumor-Detection and Visualization Using Cyanine Fluorochrome-Labeled Antibodies
Ballou B, Fisher GW, Hakala TR, Farkas DL
Biotechnology Progress, 13(5), 649, 1997 |
| 9 |
Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor Vasculature
Huang XM, Molema G, King S, Watkins L, Edgington TS, Thorpe PE
Science, 275(5299), 547, 1997 |
